Global Forum on TB Vaccines logo

Virtual Global Forum on TB Vaccines

20-22 April 2021

Advancing TB vaccines in the time of COVID-19

About the Global Forum

Due to the ongoing coronavirus pandemic, a Virtual Global Forum on TB Vaccines will be convened in April 2021 and the 6th Global Forum on TB Vaccines in Toulouse, France will be postponed to 22 - 24 February 2022. Click here for our full statement on COVID-19.

The virtual Global Forum will focus specifically on the theme of “Advancing TB Vaccine in the time of COVID-19”. It will provide an overview of the state of the field and recent progress in TB vaccine R&D against the backdrop of the COVID-19 pandemic; and convene researchers, developers, funders and other stakeholders remotely to discuss opportunities and challenges for TB vaccine R&D in these unprecedented times.

More details about the Virtual Global Forum on TB Vaccines will be available shortly on this website.

Click here for information about the 6th Global Forum on TB Vaccines.


The Virtual Global Forum on TB Vaccines will be a short, focused event with presentation and panel format sessions. The full Global Forum program format, including plenary sessions, abstract-driven sessions, and poster sessions will resume at the 6th Global Forum in Toulouse in 2022.

More information about the program will be posted on this website as it becomes available.


Registration fees, policies and other information will be posted on this website. Registration will open in January 2021.


These are extraordinary times. The world is facing a pandemic unlike any it has seen in modern times, and COVID-19 has touched every aspect of our lives. The impacts of COVID-19 on the tuberculosis (TB) pandemic and TB research and development (R&D) were swift and cut across all aspects of the global fight to eliminate this disease. Delivery of TB services and TB R&D have been interrupted, and the exciting progress and momentum of recent years is at risk.

A massive global effort is underway to develop diagnostics, treatments, and vaccines to stop the spread of SARS-CoV2, prevent severe disease and mortality, and bring an end to the COVID-19 pandemic. These efforts benefited and built on R&D for TB and other infectious diseases - from vaccine platforms to research infrastructure and trial site capacity - demonstrating the broad benefits resulting from investments in and scientific contributions to global infectious disease R&D. It will be essential that ongoing efforts to accelerate vaccine R&D for TB and other epidemic and pandemic prone diseases learn from COVID -19 and take full take advantage of the increased interest in vaccines, and the resources allocated and technologies developed for COVID-19.  

The theme for the Virtual Global Forum on TB VaccinesAdvancing TB vaccines in the time of COVID-19 – serves as a reminder that it is imperative that the world continues to support and build on recent progress, scientific breakthroughs, and momentum in TB vaccine R&D; and that synergies and opportunities for collaborations should continue to be sought to help advance the development of vaccines for TB, COVID-19 and other infectious diseases.




For information about the 5th Global Forum, please visit the following:

Learn More

Sign up for our email list to get updates about the
Global Forum on TB Vaccines.

Registration Info Form